Sex‐Specific Associations of Oral Anticoagulant Use and Cardiovascular Outcomes in Patients With Atrial Fibrillation

BACKGROUND: Sex‐specific effectiveness of rivaroxaban (RIVA), dabigatran (DABI), and warfarin in reducing myocardial infarction (MI), heart failure (HF), and all‐cause mortality among patients with atrial fibrillation are not known. We assessed sex‐specific associations of RIVA, DABI, or warfarin us...

Description complète

Enregistré dans:
Détails bibliographiques
Publié dans:J Am Heart Assoc
Auteurs principaux: Palamaner Subash Shantha, Ghanshyam, Mentias, Amgad, Inampudi, Chakradhari, Kumar, Anita A., Chaikriangkrai, Kongkiat, Bhise, Viraj, Deshmukh, Abhishek, Patel, Nileshkumar, Pancholy, Samir, Horwitz, Phillip A., Mickelsen, Steven, Bhave, Prashant D., Giudici, Michael, Oral, Hakan, Vaughan Sarrazin, Mary S.
Format: Artigo
Langue:Inglês
Publié: John Wiley and Sons Inc. 2017
Sujets:
Original Research
Accès en ligne:https://ncbi.nlm.nih.gov/pmc/articles/PMC5586467/
https://ncbi.nlm.nih.gov/pubmed/28862952
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1161/JAHA.117.006381
Tags: Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!

Documents similaires